GO Term | Evidence Code | PMID |
---|---|---|
natural killer cell mediated cytotoxicity | ||
immune response | ||
immune response-regulating signaling pathway |
GO Term | Evidence Code | PMID |
---|---|---|
protein binding | ||
HLA-B specific inhibitory MHC class I receptor activity | ||
molecular adaptor activity | ||
amyloid-beta binding |
InterPro |
---|
Immunoglobulin |
DO ID | Disease Name | Source |
---|---|---|
DOID:12365 | malaria | |
DOID:1883 | hepatitis C | |
DOID:399 | tuberculosis | |
DOID:526 | human immunodeficiency virus infectious disease |
Species | Gene ID | OrthoDB | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|---|
245615 | MGI:3612791 | MOUSE65566 | ||
245616 | MGI:2652397 | MOUSE65572 | ||
353253 | RGD:727836 | RATNO20249 | ||
456291 | 9598_0:004adb | PANTR19349 | ||
100437736 | 9601_0:004af2 | |||
100986982 | 9597_0:004f49 | |||
112131840 | 9601_0:0048fa | |||
115930123 | 9595_0:004e29 | |||
129020027 | 9600_0:004af1 | |||
129020032 | 9600_0:004a9e |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024